Whoop, a creator of fitness wearables, is introducing a novel array of tests centered on female well-being via its Whoop Labs blood analysis offering. Furthermore, the firm is incorporating a fresh functionality into its application which brings to light data concerning endocrine shifts throughout the menstrual period. Related: No Big Dance, No Job: Aut…
The emerging company announced that this collection comprises eleven distinct blood biomarkers capable of offering perspectives on elements like cycle governance and endocrine shifts: Anti-Müllerian Hormone (AMH), Progesterone, Prolactin, and Thyroid Peroxidase Antibodies (TPOAb), Free T4, Free T3, Leptin, Vitamin B12 (Cobalamin), Folate, Magnesium, and Phosphate (as Phosphorus). Related: Louis Theroux: Decoding t…
The organization asserts that assessing these biological markers will assist individuals in comprehending further details regarding perimenopause, thyroid performance, nutritional adequacy, and the robustness of bone metabolism, especially when combined with information on exertion, rest, and recuperation.
This examination will be accessible for acquisition by users starting next month. Upon Whoop’s introduction of its blood analysis offering in September 2025, a queue of more than 350,000 individuals had already formed.
Concurrently, the Whoop application’s fresh functionality, “Hormonal Symptom Insights and Predictions,” generates a framework of endocrine fluctuations across menstrual cycles, drawing upon prior information. This framework is employed to forecast potential timeframes for the subsequent menstruation, offer understandings into cycle durations, period longevity and inconsistencies, and delineate specific symptom characteristics.
The firm stated it is capable of integrating observations from this capability with laboratory outcomes for the purpose of categorizing biomarker findings into ‘ideal,’ ‘adequate,’ or ‘outside normal limits’ classifications.

Whoop additionally disseminated a fresh white paper concerning the menstrual cycle to provide clarity on the organization’s analytical framework underpinning these novel functionalities.
Techcrunch event
San Francisco, CA
|
October 13-15, 2026
Manufacturers of fitness wearables have recently been concentrating on incorporating additional functionalities and provisions aimed at female wellness, seeking to satisfy the requirements of this historically neglected segment of their clientele. At the start of this month, Oura, a producer of smart rings, unveiled a novel AI model specifically designed for female health, coupled with a conversational agent capable of delivering health data interpretations and responding to inquiries.
Whoop announced on Tuesday a 150% surge in female engagement with its offerings relative to the previous year, positioning them as its most rapidly expanding user demographic. The corporation observed that women interact 30% more frequently with its Whoop AI functionality.
During October 2025, Dorothy Kilroy, Oura’s chief commercial executive, informed TechCrunch that the enterprise’s most swiftly expanding clientele consisted of women in their second decade of life.
{content}
Source: {feed_title}

